Solius Labs earns industry accolades for its FDA-cleared Solius Pro, marking a significant advancement in personalized UVB light therapy technology for the consumer market.
Solius Labs received recognition from Fast Company for its FDA-cleared UVB light therapy device, indicating positive brand visibility and potential market traction.
Solius Labs secures industry recognition from Fast Company for its Solius Pro device, the first FDA-cleared, over-the-counter personalized UVB light therapy system. This milestone validates the company's proprietary sunlight technology and enhances its market positioning within the medical device sector.
Solius Pro is the world's first FDA-cleared, over-the-counter personalized UVB light therapy device, designed to provide controlled sunlight exposure.